It was demonstrated that CXCR4 over-expression contributes to chemoresistance of leukemic cells [94] and predicts poor prognosis in both wild-type and FMS-like tyrosine kinase 3 (FLT3)-mutated AML [95,96]. The gene discussed is CXCR4; the disease is acute myeloid leukemia.